Inventor
ANKAM RAJESH
IN12 patents
⚠️ This page may combine multiple inventors who share the name “ANKAM RAJESH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLENMARK SPECIALTY SA
8 patentsUS9750754B2Sep 5, 2017
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA6 citations82
US12303635B2May 20, 2025
Dispensing device and pharmaceutical composition for the treatment of rhinitis
GLENMARK SPECIALTY SA1 citations62
US11679210B2Jun 20, 2023
Dispensing device and pharmaceutical composition for the treatment of rhinitis
GLENMARK SPECIALTY SA1 citations60
US9937189B2Apr 10, 2018
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA1 citations60
US10765686B2Sep 8, 2020
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10561672B2Feb 18, 2020
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10517880B2Dec 31, 2019
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
US10376526B2Aug 13, 2019
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK SPECIALTY SA0 citations50
GLENMARK PHARMACEUTICALS LTD
4 patentsUS9078923B2Jul 14, 2015
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK PHARMACEUTICALS LTD24 citations90
US9370483B2Jun 21, 2016
Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
GLENMARK PHARMACEUTICALS LTD8 citations82
US12514996B2Jan 6, 2026
Metered dose inhalers of fluticasone or an ester thereof
GLENMARK PHARMACEUTICALS LTD0 citations55
US12514995B2Jan 6, 2026
Metered dose inhalers of fluticasone or an ester thereof
GLENMARK PHARMACEUTICALS LTD0 citations55